Dr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
There’s a lot of information out there about the merits and risks of vaccines. Parents are rightly concerned about making the best choices for their children amid conflicting information.
Dr. Paula Lozano describes an effort to find KP Washington members who would benefit most from preventive services.
A study helps confirm U.S. guidelines encouraging people with high-risk conditions to get vaccinated.
Dr. Michael Jackson gives a late-season report on state and national influenza patterns and his Flucaster prediction model.
Dr. Jackson leads national trial to explore improving immune responses to vaccine.
Throughout this flu season, Dr. Mike Jackson, infectious disease researcher, will provide updates on his research team's experimental influenza predictor.